LV by LeVair skin booster line is an essential series of LeVair line formulated with advanced biotechnology to deeply revitalize and rejuvenate the skin. Each booster combines high-performance ingredients - Glutathione 6%, Hyaluronic Acid, Succinic Acid, Polynucleotides (PN), and multifunctional Peptides - delivering synergistic effects that target dullness, dehydration, uneven tone, and signs of aging. Carefully engineered to restore skin health from within, LV by LeVair provides visible improvements in elasticity, brightness, and texture with every treatment.

LV by LeVair is a carefully designed sub-line under the LeVair brand, created to deliver visible, reliable skin results at a more accessible price point - without compromising on quality.
This budget-friendly alternative focuses on refined formulas, targeted ingredients, and real performance, making advanced aesthetic science easier to use, easier to understand, and easier to integrate into daily practice.

Each LV booster is built around one clear skin concern, avoiding unnecessary complexity while maintaining the high standards LeVair is known for. One philosophy. Four targeted skin boosters.

INDICATIONS

• LV Glutathione 6%: An antioxidant-rich booster designed to reduce hyper pigmentation and brighten overall skin tone.
• LV Polynucleotides Skin Booster: A dual-function formulation with PN and H-HA that hydrates and accelerates skin regeneration through DNA repair and extracellular matrix support.
• LV Dual HA Skin Booster: A hydrating and retexturizing formula with 40mg of Dual HA developed to improve skin tone, elasticity, and metabolic function.
• LV AC Advanced Clear Perfection Complex: A clarifying and calming skin booster that exfoliates, controls breakouts, reduces excess oil, and strengthens the skin barrier for clearer, balanced skin.

IMPORTANT SAFETY INFORMATION

LV products should not be used in individuals with known hypersensitivity to any of the active components including polynucleotides, hyaluronic acid, glutathione, succinic acid, peptides, or growth factors. Patients with active infections, inflammation, or skin lesions at the treatment site, or those diagnosed with autoimmune disorders or under immunosuppressive therapy, should defer treatment. Use during pregnancy and breastfeeding has not been established and is not recommended. Additionally, caution should be exercised in patients with a history of hypertrophic scarring, keloid formation, or pigmentation disorders.

WARNINGS

Avoid intravascular injection. Injecting into or near blood vessels may result in severe complications, including embolization, ischemia, or tissue necrosis. To minimize this risk, practitioners must aspirate before injection and inject slowly with minimal pressure. While rare, intravascular injection of skin boosters may lead to adverse events such as vision abnormalities, skin blanching, or neurological symptoms. Any sign of unexpected pain, visual change, or discoloration should prompt immediate cessation of injection and urgent medical evaluation.

LV products should not be injected into areas with active acne, eczema, or other inflammatory dermatoses. The use of LV boosters in combination with laser treatments, aggressive peels, or other procedures that elicit a strong dermal response should be performed with caution to avoid hypersensitivity or unwanted inflammatory reactions.

PRECAUTIONS

All LV skin boosters should be administered by licensed medical professionals with adequate training in facial anatomy, dermal injection techniques, and the identification and management of adverse events. Practitioners should be familiar with the specific characteristics of each product in the LV line, including appropriate depth and injection volume.

Patients should be informed of the risks, benefits, and post-treatment care protocols. Prior to injection, a full medical history should be reviewed, especially regarding allergies, immunological disorders, recent procedures, or current medications that may increase bleeding or healing complications.

The safety and efficacy of using these products outside of the indicated treatment areas have not been evaluated in controlled clinical studies.

ADVERSE EVENTS

The most commonly reported adverse events include injection site reactions such as redness, swelling, tenderness, bruising, itching, or temporary firmness. In most cases, these effects are mild to moderate and resolve within a few days. Rare but serious complications may include hypersensitivity reactions, granuloma formation, or delayed-onset nodules.

Patients using blood-thinning medications such as aspirin, NSAIDs, or anticoagulants may experience increased bruising or bleeding. Those with damaged skin barriers near the treatment area may be at greater risk of irritation or infection. As with all injectable products, proper aseptic technique must be observed to minimize the risk of contamination and post-procedure infection.